Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Viracta Therapeutics, Inc. (VIRX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
25 Feb 2024
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
102,306
-3%
3,405
$0.73
$2,493.14
SELL
25 Aug 2023
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
95,653
-3%
3,512
$1.45
$5,092.40
SELL
25 May 2023
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
92,277
-3%
3,635
$1.42
$5,160.25
SELL
25 Feb 2023
Rojkjaer Lisa
Chief Medical Officer, Officer
Viracta Therapeutics, Inc.
(VIRX)
48,087
-4%
2,156
$1.68
$3,624.67
SELL
25 Feb 2023
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
89,023
-3%
3,599
$1.68
$6,050.64
SELL
25 Aug 2022
Rojkjaer Lisa
Chief Medical Officer, Officer
Viracta Therapeutics, Inc.
(VIRX)
44,105
-4%
2,190
$4.01
$8,785.84
SELL
25 Aug 2022
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
82,376
-4%
3,655
$4.02
$14,679.21
SELL
25 Aug 2022
ROYSTON IVOR
CEO & President, Director, Officer
Viracta Therapeutics, Inc.
(VIRX)
612,770
-2%
13,379
$4.01
$53,656.48
SELL
25 May 2022
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
79,142
-4%
3,596
$1.90
$6,836.36
SELL
25 May 2022
Rojkjaer Lisa
Chief Medical Officer, Officer
Viracta Therapeutics, Inc.
(VIRX)
42,168
-4%
2,154
$1.90
$4,094.97
SELL
25 May 2022
ROYSTON IVOR
CEO & President, Director, Officer
Viracta Therapeutics, Inc.
(VIRX)
600,930
-2%
13,162
$1.90
$25,022.28
SELL
25 Feb 2022
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
75,849
-5%
3,998
$2.78
$11,112.44
SELL
25 Feb 2022
Rojkjaer Lisa
Chief Medical Officer, Officer
Viracta Therapeutics, Inc.
(VIRX)
40,195
-5%
2,395
$2.78
$6,656.90
SELL
25 Feb 2022
ROYSTON IVOR
CEO & President, Director, Officer
Viracta Therapeutics, Inc.
(VIRX)
588,873
-2%
14,635
$2.78
$40,677.98
SELL
25 Nov 2021
Chevallard Daniel R.
CFO and COO, Officer
Viracta Therapeutics, Inc.
(VIRX)
72,958
-9%
7,579
$4.81
$36,463.76
SELL
25 Nov 2021
Rojkjaer Lisa
Chief Medical Officer, Officer
Viracta Therapeutics, Inc.
(VIRX)
38,463
-10%
4,541
$4.81
$21,847.46
SELL
25 Nov 2021
ROYSTON IVOR
CEO & President, Director, Officer
Viracta Therapeutics, Inc.
(VIRX)
571,289
-4%
27,747
$4.81
$133,495.16
BUY
15 Nov 2021
ROYSTON IVOR
CEO & President, Director, Officer
Viracta Therapeutics, Inc.
(VIRX)
548,599
+1%
8,000
$5.56
$44,480.00
BUY
29 May 2020
Gullotta Tina
VP, Finance, Officer
SUNESIS PHARMACEUTICALS INC
(SNSS)
20,500
+0%
171.429
$11.60
$1,989.00
BUY
31 Mar 2020
Quinn William P.
See Remarks, Officer
SUNESIS PHARMACEUTICALS INC
(SNSS)
127,697
+0%
342.857
$17.70
$6,069.60
BUY
15 Jul 2019
Aisling Capital IV, LP
10% Owner
SUNESIS PHARMACEUTICALS INC
(SNSS)
10,100,000
+0%
71,428.57
$21.00
$1,500,000.00
BUY
10 Dec 2018
Quinn William P.
CFO,Sr.V.P. Finance, Corp.Dev., Officer
SUNESIS PHARMACEUTICALS INC
(SNSS)
52,000
+2%
1,142.857
$16.45
$18,800.00
BUY
2 Nov 2017
MPM Oncology Impact Management GP LLC
10% Owner
SUNESIS PHARMACEUTICALS INC
(SNSS)
3,331,500
+0%
2,328.572
$97.06
$226,001.00
BUY
27 Oct 2017
Misfeldt Dayton
Director
SUNESIS PHARMACEUTICALS INC
(SNSS)
1,598,260
+0%
11,428.571
$70.00
$800,000.00
BUY
8 Dec 2016
Parker Geoffrey M.
Director
SUNESIS PHARMACEUTICALS INC
(SNSS)
65,745
+0%
106.857
$135.48
$14,476.96
BUY
26 May 2016
Parker Geoffrey M.
Director
SUNESIS PHARMACEUTICALS INC
(SNSS)
62,005
+0%
45.238
$98.47
$4,454.55
BUY
24 May 2016
Parker Geoffrey M.
Director
SUNESIS PHARMACEUTICALS INC
(SNSS)
52,505
+0%
250.024
$99.25
$24,813.93
Home